Urinary DEHP metabolites and fasting time in NHANES

Exposure assessment analyses conducted in Europe have concluded that the primary pathway of exposure to di(2-ethylhexyl) phthalate (DEHP) is through the diet. The purpose of this study is to evaluate whether urinary DEHP metabolite data from the 2007–2008 National Health and Nutritional Examination Survey (NHANES) demonstrate relationships with reported food-fasting time consistent with diet as the predominant exposure pathway. Previous controlled-dosing data demonstrate that DEHP metabolite concentrations in urine first rise and then decline over time, with first-order elimination becoming evident at about 6 h post exposure. Regression of the concentrations of four key DEHP metabolites vs reported fasting times between 6 and 18 h in adults resulted in apparent population-based urinary elimination half-lives, consistent with those previously determined in a controlled-dosing experiment, supporting the importance of the dietary pathway for DEHP. For fasting times less than about 6 h, sampling session (morning, afternoon, or evening) affected the measured metabolite concentrations. Evening samples showed the highest metabolite concentrations, supporting a hypothesis of recent daily dietary exposures from multiple meals, whereas morning and afternoon samples for fasting times less than 6 h were similar and somewhat lower than evening samples, consistent with less-substantial early day dietary exposure. Variations in children's bodyweight-normalized creatinine excretion and food intake rates contribute to a strong inverse relationship between urinary DEHP metabolite concentrations and age under age 18. Finally, a previously published pharmacokinetic model for DEHP demonstrates that time since previous urinary void, a parameter not measured in NHANES, is predicted to result in non-random effects on measured urinary concentrations.

[1]  Ian T. Cousins,et al.  Assessment of Critical Exposure Pathways , 2003 .

[2]  T. Remer,et al.  Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. , 2002, The American journal of clinical nutrition.

[3]  P. Albro,et al.  Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. , 1982, Environmental health perspectives.

[4]  K. Hungerbühler,et al.  What Are the Sources of Exposure to Eight Frequently Used Phthalic Acid Esters in Europeans? , 2006, Risk analysis : an official publication of the Society for Risk Analysis.

[5]  Holger M Koch,et al.  A critical evaluation of the creatinine correction approach: Can it underestimate intakes of phthalates? A case study with di-2-ethylhexyl phthalate , 2011, Journal of Exposure Science and Environmental Epidemiology.

[6]  Holger M Koch,et al.  A simple pharmacokinetic model to characterize exposure of Americans to Di-2-ethylhexyl phthalate , 2010, Journal of Exposure Science and Environmental Epidemiology.

[7]  Holger M. Koch,et al.  New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP , 2005, Archives of Toxicology.

[8]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.

[9]  Antonia M. Calafat,et al.  Variability over 1 Week in the Urinary Concentrations of Metabolites of Diethyl Phthalate and Di(2-Ethylhexyl) Phthalate among Eight Adults: An Observational Study , 2010, Environmental health perspectives.

[10]  Antonia M. Calafat,et al.  Integrating Biomonitoring Exposure Data into the Risk Assessment Process: Phthalates [Diethyl Phthalate and Di(2-ethylhexyl) Phthalate] as a Case Study , 2006, Environmental health perspectives.

[11]  Charles A. Staples,et al.  Modeling Human Exposure to Phthalate Esters: A Comparison of Indirect and Biomonitoring Estimation Methods , 2011, Human and ecological risk assessment : HERA.

[12]  Bernhard Liebl,et al.  Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. , 2007, Environment international.

[13]  L L Needham,et al.  Human exposure estimates for phthalates. , 2000, Environmental health perspectives.

[14]  T. Brüning,et al.  Assessing exposure to phthalates - the human biomonitoring approach. , 2011, Molecular nutrition & food research.

[15]  Marike Kolossa-Gehring,et al.  Di-n-butylphthalate and butylbenzylphthalate — urinary metabolite levels and estimated daily intakes: pilot study for the German Environmental Survey on children , 2007, Journal of Exposure Science and Environmental Epidemiology.

[16]  Sean M Hays,et al.  Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7). , 2009, Regulatory toxicology and pharmacology : RTP.

[17]  S. Swan,et al.  Bisphenol A Data in NHANES Suggest Longer than Expected Half-Life, Substantial Nonfood Exposure, or Both , 2009, Environmental health perspectives.